Full-Time

Product Manager

Infectious Disease Assays

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Global medical technology and diagnostics provider

Compensation Overview

$99.6k - $164.3k/yr

Mid, Senior

Sparks, MD, USA

Remote

Candidate must be willing to travel to Sparks, MD 1 week out of the month.

Category
Technical Product Management
Product Management
Product
Required Skills
Product Management
Financial analysis
Requirements
  • Degree level qualification; or equivalent combination of education and experience.
  • 3+ years of relevant product management experience within diagnostic or life sciences industries
  • Solid product management foundation in managing instrumentation portfolios through their entire lifecycle, from development and commercialization to obsolescence. Experience with molecular instrumentation is strongly preferred.
  • Proven success in leading global new product development projects through the stage gate process
  • Knowledge of molecular diagnostic laboratory instrumentation and workflow
  • Strong analytical skills with ability to conduct and interpret financial analysis related to the product portfolio and translate customer insights into actionable strategies
  • Record of leading and managing cross-functional teams and navigating within a matrix organization to achieve goals
  • Excellent communication, presentation, and writing skills, with comfort in communicating across various levels of stakeholders
  • Results-driven and proactive in finding solutions, with the ability to think critically to overcome potential business hurdles and complete tasks
  • Willing to travel up to 25%
Responsibilities
  • Lead the development and execution of multigeneration product portfolio strategy through coordination with cross-functional teams within a matrixed organization
  • Drive the new product development and introduction process, ensuring successful launch and commercialization
  • Work cross-functionally to manage the overall life cycle of assigned product lines, including product changes, inventory needs, production planning, and quality to ensure products are positioned competitively globally
  • Evaluate and craft financially sound business proposals for new products and partnerships that will serve to expand portfolio revenue
  • Collect and monitor voice of customer, competitive insights, market, and technology trends to shape strategies and roadmaps
  • Ensure assigned products are receptive to market needs, driving continuous improvements where needed to maintain and/or improve market penetration and share position
  • Establish pricing positioning, monitor product pricing vs. the competition, lead product-specific price/margin improvement initiatives, and participate in global price changes
  • Partner with R&D, Operations, Sales, and Marketing to adjust the product line, products, and related features to drive both market share and financial results
  • Conduct business analyses for assigned products/product lines to support business planning and generate actionable insights
  • Collaborate with marketing and commercial teams to develop and execute marketing plans and demand generation to achieve product line objectives
  • Ensure appropriate technical support for sales and field applications teams, including assistance with communicating and positioning products
  • Effectively communicate product forecasts, working with global regions, planners, and supply chain to ensure accurate demand planning and product build; actively represent in Demand, Supply, and Operational Planning

BD (Becton, Dickinson and Company) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on medication management and delivery; BD Life Sciences, which offers products for safe collection and transport of diagnostic specimens; and BD Interventional, which provides devices for minimally invasive surgeries. The company generates revenue by selling medical devices, laboratory equipment, and diagnostic products. BD stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare.

Company Size

10,001+

Company Stage

IPO

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...